{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:45:59Z","timestamp":1792107959006,"version":"4.4.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1K23DC017983-01A1"],"award-info":[{"award-number":["1K23DC017983-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1T32MH112510"],"award-info":[{"award-number":["1T32MH112510"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U54HD082008"],"award-info":[{"award-number":["U54HD082008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U54HD104461"],"award-info":[{"award-number":["U54HD104461"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K23 HD101416"],"award-info":[{"award-number":["K23 HD101416"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["F31 HD113221-01A1"],"award-info":[{"award-number":["F31 HD113221-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY023037"],"award-info":[{"award-number":["R01EY023037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS123499"],"award-info":[{"award-number":["R21NS123499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["GRFP"],"award-info":[{"award-number":["GRFP"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000297","name":"FRAXA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008152","name":"Autism Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["SFARI 575135"],"award-info":[{"award-number":["SFARI 575135"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/S008276\/1"],"award-info":[{"award-number":["BB\/S008276\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Predicting clinical therapeutic outcomes from animal studies using conserved electrophysiological phenotypes could facilitate developing treatments for neuropsychiatric disorders. Alpha oscillations in human resting-state electroencephalogram recordings are altered in many disorders, but whether these disruptions exist in mouse models is unknown. Here, we employed a uniform analytical method to show in males with fragile X syndrome (FXS) that alpha oscillations in humans and alpha-like oscillations in the visual cortex of\n                    <jats:italic>Fmr1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>-\/y<\/jats:italic>\n                    <\/jats:sup>\n                    mice are slowed, with a stronger phenotype in adults than juveniles and a juvenile-specific power phenotype in both species. We find that alpha-like oscillations are disrupted by deletion of\n                    <jats:italic>Fmr1<\/jats:italic>\n                    in cortical excitatory neurons and glia, reflect differential activity of two classes of GABAergic interneurons, and are more sensitive to activation of GABA\n                    <jats:sub>B<\/jats:sub>\n                    receptors by Arbaclofen in wild-type than\n                    <jats:italic>Fmr1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>-\/y<\/jats:italic>\n                    <\/jats:sup>\n                    mice. Our framework reveals evolutionary conservation of alpha oscillation disruptions, enables a deeper understanding of FXS pathophysiology, and narrows the gap between treatment promise and practice.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-69243-0","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T11:25:22Z","timestamp":1770636322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-\/y mice"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6027-9453","authenticated-orcid":false,"given":"Sara S.","family":"Kornfeld-Sylla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Gelegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4438-3416","authenticated-orcid":false,"given":"Jordan E.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-4539","authenticated-orcid":false,"given":"Francesca A.","family":"Chaloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4838-3012","authenticated-orcid":false,"given":"Michael","family":"Khela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell J.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S. B.","family":"Finnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Ethridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam F.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4694-8564","authenticated-orcid":false,"given":"Carol L.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9903-2541","authenticated-orcid":false,"given":"Mark F.","family":"Bear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"69243_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s11689-016-9179-0","volume":"8","author":"M Lee","year":"2016","unstructured":"Lee, M., Martin, G. E., Berry-Kravis, E. & Losh, M. A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome. J. Neurodev. Disord. 8, 47 (2016).","journal-title":"J. Neurodev. Disord."},{"key":"69243_CR2","doi-asserted-by":"publisher","unstructured":"Coffman, M. C. et al. Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome. Brain Sci. 10, https:\/\/doi.org\/10.3390\/brainsci10040213 (2020).","DOI":"10.3390\/brainsci10040213"},{"key":"69243_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.genom.8.080706.092249","volume":"8","author":"O Penagarikano","year":"2007","unstructured":"Penagarikano, O., Mulle, J. G. & Warren, S. T. The pathophysiology of fragile X syndrome. Annu. Rev. Genomics Hum. Genet. 8, 109\u2013129 (2007).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"69243_CR4","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/hmg\/ddy099","volume":"27","author":"S Jacquemont","year":"2018","unstructured":"Jacquemont, S. et al. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome. Hum. Mol. Genet. 27, 2039\u20132051 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"69243_CR5","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.celrep.2017.02.075","volume":"18","author":"LJ Stoppel","year":"2017","unstructured":"Stoppel, L. J. et al. beta-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X. Cell Rep. 18, 2807\u20132814 (2017).","journal-title":"Cell Rep."},{"key":"69243_CR6","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/nn.3864","volume":"17","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-\/y) mice. Nat. Neurosci. 17, 1701\u20131709 (2014).","journal-title":"Nat. Neurosci."},{"key":"69243_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuron.2015.06.017","volume":"87","author":"A Contractor","year":"2015","unstructured":"Contractor, A., Klyachko, V. A. & Portera-Cailliau, C. Altered Neuronal and Circuit Excitability in Fragile X Syndrome. Neuron 87, 699\u2013715 (2015).","journal-title":"Neuron"},{"key":"69243_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-med-061109-134644","volume":"62","author":"DD Krueger","year":"2011","unstructured":"Krueger, D. D. & Bear, M. F. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu. Rev. Med. 62, 411\u2013429 (2011).","journal-title":"Annu. Rev. Med."},{"key":"69243_CR9","doi-asserted-by":"publisher","first-page":"1171895","DOI":"10.3389\/fnins.2023.1171895","volume":"17","author":"A Tempio","year":"2023","unstructured":"Tempio, A., Boulksibat, A., Bardoni, B. & Delhaye, S. Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments. Front Neurosci. 17, 1171895 (2023).","journal-title":"Front Neurosci."},{"key":"69243_CR10","doi-asserted-by":"publisher","first-page":"805929","DOI":"10.3389\/fnmol.2021.805929","volume":"14","author":"X Liu","year":"2021","unstructured":"Liu, X., Kumar, V., Tsai, N. P. & Auerbach, B. D. Hyperexcitability and Homeostasis in Fragile X Syndrome. Front Mol. Neurosci. 14, 805929 (2021).","journal-title":"Front Mol. Neurosci."},{"key":"69243_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrd.2017.221","volume":"17","author":"EM Berry-Kravis","year":"2018","unstructured":"Berry-Kravis, E. M. et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat. Rev. Drug Discov. 17, 280\u2013299 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"69243_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-9554-7_1","volume":"2011","author":"A Kaffman","year":"2019","unstructured":"Kaffman, A., White, J. D., Wei, L., Johnson, F. K. & Krystal, J. H. Enhancing the Utility of Preclinical Research in Neuropsychiatry Drug Development. Methods Mol. Biol. 2011, 3\u201322 (2019).","journal-title":"Methods Mol. Biol."},{"key":"69243_CR13","doi-asserted-by":"publisher","first-page":"R909","DOI":"10.1016\/j.cub.2018.07.046","volume":"28","author":"JRT Howe","year":"2018","unstructured":"Howe, J. R. T. et al. The mouse as a model for neuropsychiatric drug development. Curr. Biol. 28, R909\u2013R914 (2018).","journal-title":"Curr. Biol."},{"key":"69243_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01796-2","volume":"12","author":"A Kenny","year":"2022","unstructured":"Kenny, A., Wright, D. & Stanfield, A. C. EEG as a translational biomarker and outcome measure in fragile X syndrome. Transl. Psychiatry 12, 34 (2022).","journal-title":"Transl. Psychiatry"},{"key":"69243_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/WCO.0000000000000181","volume":"28","author":"SS Jeste","year":"2015","unstructured":"Jeste, S. S., Frohlich, J. & Loo, S. K. Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders. Curr. Opin. Neurol. 28, 110\u2013116 (2015).","journal-title":"Curr. Opin. Neurol."},{"key":"69243_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnint.2019.00045","volume":"13","author":"JB Ewen","year":"2019","unstructured":"Ewen, J. B., Sweeney, J. A. & Potter, W. Z. Conceptual, Regulatory and Strategic Imperatives in the Early Days of EEG-Based Biomarker Validation for Neurodevelopmental Disabilities. Front Integr. Neurosci. 13, 45 (2019).","journal-title":"Front Integr. Neurosci."},{"key":"69243_CR17","doi-asserted-by":"publisher","unstructured":"Berry-Kravis, E. et al. Effects of AFQ056 on language learning in fragile X syndrome. J Clin Invest https:\/\/doi.org\/10.1172\/JCI171723 (2023).","DOI":"10.1172\/JCI171723"},{"key":"69243_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpsychires.2021.03.057","volume":"138","author":"EG Smith","year":"2021","unstructured":"Smith, E. G. et al. Sex differences in resting EEG power in Fragile X Syndrome. J. Psychiatr. Res 138, 89\u201395 (2021).","journal-title":"J. Psychiatr. Res"},{"key":"69243_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s42003-022-03395-9","volume":"5","author":"EV Pedapati","year":"2022","unstructured":"Pedapati, E. V. et al. Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Commun. Biol. 5, 442 (2022).","journal-title":"Commun. Biol."},{"key":"69243_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11689-017-9191-z","volume":"9","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J. Neurodev. Disord. 9, 11 (2017).","journal-title":"J. Neurodev. Disord."},{"key":"69243_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s11689-024-09570-9","volume":"16","author":"M Proteau-Lemieux","year":"2024","unstructured":"Proteau-Lemieux, M. et al. Specific EEG resting state biomarkers in FXS and ASD. J. Neurodev. Disord. 16, 53 (2024).","journal-title":"J. Neurodev. Disord."},{"key":"69243_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-021-00425-x","volume":"12","author":"CL Wilkinson","year":"2021","unstructured":"Wilkinson, C. L. & Nelson, C. A. Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability. Mol. Autism 12, 17 (2021).","journal-title":"Mol. Autism"},{"key":"69243_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2018.03.012","volume":"115","author":"JW Lovelace","year":"2018","unstructured":"Lovelace, J. W., Ethell, I. M., Binder, D. K. & Razak, K. A. Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome. Neurobiol. Dis. 115, 39\u201348 (2018).","journal-title":"Neurobiol. Dis."},{"key":"69243_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nbd.2019.01.002","volume":"124","author":"S Goswami","year":"2019","unstructured":"Goswami, S., Cavalier, S., Sridhar, V., Huber, K. M. & Gibson, J. R. Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome. Neurobiol. Dis. 124, 563\u2013572 (2019).","journal-title":"Neurobiol. Dis."},{"key":"69243_CR25","doi-asserted-by":"publisher","first-page":"110182","DOI":"10.1016\/j.neuropharm.2024.110182","volume":"262","author":"P Janz","year":"2025","unstructured":"Janz, P., Bainier, M., Marashli, S., Gross, S. & Redondo, R. L. Clinically-probed mechanisms of action in Fragile-X syndrome fail to normalize translational EEG phenotypes in Fmr1 knockout mice. Neuropharmacology 262, 110182 (2025).","journal-title":"Neuropharmacology"},{"key":"69243_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75893-x","volume":"10","author":"N Kozono","year":"2020","unstructured":"Kozono, N., Okamura, A., Honda, S., Matsumoto, M. & Mihara, T. Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome. Sci. Rep. 10, 18799 (2020).","journal-title":"Sci. Rep."},{"key":"69243_CR27","first-page":"1386","volume":"27","author":"J Berzhanskaya","year":"2017","unstructured":"Berzhanskaya, J. et al. Disrupted Cortical State Regulation in a Rat Model of Fragile X Syndrome. Cereb. Cortex 27, 1386\u20131400 (2017).","journal-title":"Cereb. Cortex"},{"key":"69243_CR28","doi-asserted-by":"publisher","first-page":"104794","DOI":"10.1016\/j.nbd.2020.104794","volume":"138","author":"CR Jonak","year":"2020","unstructured":"Jonak, C. R., Lovelace, J. W., Ethell, I. M., Razak, K. A. & Binder, D. K. Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome. Neurobiol. Dis. 138, 104794 (2020).","journal-title":"Neurobiol. Dis."},{"key":"69243_CR29","doi-asserted-by":"publisher","first-page":"106496","DOI":"10.1016\/j.nbd.2024.106496","volume":"195","author":"CR Jonak","year":"2024","unstructured":"Jonak, C. R. et al. Phenotypic analysis of multielectrode array EEG biomarkers in developing and adult male Fmr1 KO mice. Neurobiol. Dis. 195, 106496 (2024).","journal-title":"Neurobiol. Dis."},{"key":"69243_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.biopsycho.2012.11.013","volume":"92","author":"MJ Van der Molen","year":"2013","unstructured":"Van der Molen, M. J. & Van der Molen, M. W. Reduced alpha and exaggerated theta power during the resting-state EEG in fragile X syndrome. Biol. Psychol. 92, 216\u2013219 (2013).","journal-title":"Biol. Psychol."},{"key":"69243_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72935-6","volume":"14","author":"LE Ethridge","year":"2024","unstructured":"Ethridge, L. E. et al. Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome. Sci. Rep. 14, 22982 (2024).","journal-title":"Sci. Rep."},{"key":"69243_CR32","doi-asserted-by":"publisher","unstructured":"Liu, R. et al. Reliability of resting-state electrophysiology in fragile X syndrome. Biomark Neuropsychiatry 9, https:\/\/doi.org\/10.1016\/j.bionps.2023.100070 (2023).","DOI":"10.1016\/j.bionps.2023.100070"},{"key":"69243_CR33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/psyp.12043","volume":"50","author":"TH Grandy","year":"2013","unstructured":"Grandy, T. H. et al. Peak individual alpha frequency qualifies as a stable neurophysiological trait marker in healthy younger and older adults. Psychophysiology 50, 570\u2013582 (2013).","journal-title":"Psychophysiology"},{"key":"69243_CR34","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1528-1157.1999.tb00824.x","volume":"40","author":"SA Musumeci","year":"1999","unstructured":"Musumeci, S. A. et al. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40, 1092\u20131099 (1999).","journal-title":"Epilepsia"},{"key":"69243_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijdevneu.2014.07.002","volume":"38","author":"TT Heard","year":"2014","unstructured":"Heard, T. T. et al. EEG abnormalities and seizures in genetically diagnosed Fragile X syndrome. Int J. Dev. Neurosci. 38, 155\u2013160 (2014).","journal-title":"Int J. Dev. Neurosci."},{"key":"69243_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/1073858405277450","volume":"11","author":"SW Hughes","year":"2005","unstructured":"Hughes, S. W. & Crunelli, V. Thalamic mechanisms of EEG alpha rhythms and their pathological implications. Neuroscientist 11, 357\u2013372 (2005).","journal-title":"Neuroscientist"},{"key":"69243_CR37","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1111\/ejn.13747","volume":"48","author":"MS Clayton","year":"2018","unstructured":"Clayton, M. S., Yeung, N. & Cohen Kadosh, R. The many characters of visual alpha oscillations. Eur. J. Neurosci. 48, 2498\u20132508 (2018).","journal-title":"Eur. J. Neurosci."},{"key":"69243_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s11689-021-09392-z","volume":"13","author":"S Hamburg","year":"2021","unstructured":"Hamburg, S., Bush, D., Strydom, A. & Startin, C. M. Comparison of resting-state EEG between adults with Down syndrome and typically developing controls. J. Neurodev. Disord. 13, 48 (2021).","journal-title":"J. Neurodev. Disord."},{"key":"69243_CR39","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/cercor\/bhz043","volume":"29","author":"S Hamburg","year":"2019","unstructured":"Hamburg, S., Rosch, R., Startin, C. M., Friston, K. J. & Strydom, A. Dynamic Causal Modeling of the Relationship between Cognition and Theta-alpha Oscillations in Adults with Down Syndrome. Cereb. Cortex 29, 2279\u20132290 (2019).","journal-title":"Cereb. Cortex"},{"key":"69243_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/ejn.13645","volume":"47","author":"A Dickinson","year":"2018","unstructured":"Dickinson, A., DiStefano, C., Senturk, D. & Jeste, S. S. Peak alpha frequency is a neural marker of cognitive function across the autism spectrum. Eur. J. Neurosci. 47, 643\u2013651 (2018).","journal-title":"Eur. J. Neurosci."},{"key":"69243_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02681-2","volume":"13","author":"WS Neo","year":"2023","unstructured":"Neo, W. S., Foti, D., Keehn, B. & Kelleher, B. Resting-state EEG power differences in autism spectrum disorder: a systematic review and meta-analysis. Transl. Psychiatry 13, 389 (2023).","journal-title":"Transl. Psychiatry"},{"key":"69243_CR42","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1002\/hbm.24598","volume":"40","author":"JC Edgar","year":"2019","unstructured":"Edgar, J. C. et al. Abnormal maturation of the resting-state peak alpha frequency in children with autism spectrum disorder. Hum. Brain Mapp. 40, 3288\u20133298 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"69243_CR43","doi-asserted-by":"publisher","first-page":"101693","DOI":"10.1016\/j.nicl.2019.101693","volume":"22","author":"M Murphy","year":"2019","unstructured":"Murphy, M. & Ongur, D. Decreased peak alpha frequency and impaired visual evoked potentials in first episode psychosis. Neuroimage Clin. 22, 101693 (2019).","journal-title":"Neuroimage Clin."},{"key":"69243_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97303-6","volume":"11","author":"IS Ramsay","year":"2021","unstructured":"Ramsay, I. S., Lynn, P. A., Schermitzler, B. & Sponheim, S. R. Individual alpha peak frequency is slower in schizophrenia and related to deficits in visual perception and cognition. Sci. Rep. 11, 17852 (2021).","journal-title":"Sci. Rep."},{"key":"69243_CR45","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/ejn.16244","volume":"59","author":"A Nakhnikian","year":"2024","unstructured":"Nakhnikian, A. et al. Spectral decomposition of resting state electroencephalogram reveals unique theta\/alpha activity in schizophrenia. Eur. J. Neurosci. 59, 1946\u20131960 (2024).","journal-title":"Eur. J. Neurosci."},{"key":"69243_CR46","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/schbul\/sbaa184","volume":"47","author":"AB Van Derveer","year":"2021","unstructured":"Van Derveer, A. B. et al. A Role for Somatostatin-Positive Interneurons in Neuro-Oscillatory and Information Processing Deficits in Schizophrenia. Schizophr. Bull. 47, 1385\u20131398 (2021).","journal-title":"Schizophr. Bull."},{"key":"69243_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnhum.2010.00232","volume":"4","author":"JJ Allen","year":"2010","unstructured":"Allen, J. J. & Cohen, M. X. Deconstructing the \u201cresting\u201d state: exploring the temporal dynamics of frontal alpha asymmetry as an endophenotype for depression. Front. Hum. Neurosci. 4, 232 (2010).","journal-title":"Front. Hum. Neurosci."},{"key":"69243_CR48","doi-asserted-by":"publisher","unstructured":"Ippolito, G. et al. The Role of Alpha Oscillations among the Main Neuropsychiatric Disorders in the Adult and Developing Human Brain: Evidence from the Last 10 Years of Research. Biomedicines 10. https:\/\/doi.org\/10.3390\/biomedicines10123189.","DOI":"10.3390\/biomedicines10123189"},{"key":"69243_CR49","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41593-020-00744-x","volume":"23","author":"T Donoghue","year":"2020","unstructured":"Donoghue, T. et al. Parameterizing neural power spectra into periodic and aperiodic components. Nat. Neurosci. 23, 1655\u20131665 (2020).","journal-title":"Nat. Neurosci."},{"key":"69243_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50204-4","volume":"15","author":"CL Wilkinson","year":"2024","unstructured":"Wilkinson, C. L. et al. Developmental trajectories of EEG aperiodic and periodic components in children 2-44 months of age. Nat. Commun. 15, 5788 (2024).","journal-title":"Nat. Commun."},{"key":"69243_CR51","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.dcn.2021.100969","volume":"50","author":"D Cellier","year":"2021","unstructured":"Cellier, D., Riddle, J., Petersen, I. & Hwang, K. The development of theta and alpha neural oscillations from ages 3 to 24 years. Dev. Cogn. Neurosci. 50, 100969 (2021).","journal-title":"Dev. Cogn. Neurosci."},{"key":"69243_CR52","doi-asserted-by":"publisher","first-page":"101146","DOI":"10.1016\/j.dcn.2022.101146","volume":"57","author":"J Freschl","year":"2022","unstructured":"Freschl, J., Azizi, L. A., Balboa, L., Kaldy, Z. & Blaser, E. The development of peak alpha frequency from infancy to adolescence and its role in visual temporal processing: A meta-analysis. Dev. Cogn. Neurosci. 57, 101146 (2022).","journal-title":"Dev. Cogn. Neurosci."},{"key":"69243_CR53","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.neuron.2018.12.009","volume":"101","author":"Y Senzai","year":"2019","unstructured":"Senzai, Y., Fernandez-Ruiz, A. & Buzsaki, G. Layer-Specific Physiological Features and Interlaminar Interactions in the Primary Visual Cortex of the Mouse. Neuron 101, 500\u2013513.e505 (2019).","journal-title":"Neuron"},{"key":"69243_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuron.2021.10.005","volume":"110","author":"DB Nestvogel","year":"2022","unstructured":"Nestvogel, D. B. & McCormick, D. A. Visual thalamocortical mechanisms of waking state-dependent activity and alpha oscillations. Neuron 110, 120\u2013138.e124 (2022).","journal-title":"Neuron"},{"key":"69243_CR55","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-018-0516-1","volume":"562","author":"AB Saleem","year":"2018","unstructured":"Saleem, A. B., Diamanti, E. M., Fournier, J., Harris, K. D. & Carandini, M. Coherent encoding of subjective spatial position in visual cortex and hippocampus. Nature 562, 124\u2013127 (2018).","journal-title":"Nature"},{"key":"69243_CR56","doi-asserted-by":"publisher","unstructured":"Norris, J. E. et al. Hemispheric Utilization of Alpha Oscillatory Dynamics as a Unique Biomarker of Neural Compensation in Females with Fragile X Syndrome. ACS Chem. Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.2c00404 (2022).","DOI":"10.1021\/acschemneuro.2c00404"},{"key":"69243_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s13238-021-00878-z","volume":"13","author":"C Yang","year":"2022","unstructured":"Yang, C. et al. Restoration of FMRP expression in adult V1 neurons rescues visual deficits in a mouse model of fragile X syndrome. Protein Cell 13, 203\u2013219 (2022).","journal-title":"Protein Cell"},{"key":"69243_CR58","doi-asserted-by":"publisher","first-page":"105577","DOI":"10.1016\/j.nbd.2021.105577","volume":"162","author":"M Rais","year":"2022","unstructured":"Rais, M. et al. Functional consequences of postnatal interventions in a mouse model of Fragile X syndrome. Neurobiol. Dis. 162, 105577 (2022).","journal-title":"Neurobiol. Dis."},{"key":"69243_CR59","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.nbd.2005.08.019","volume":"21","author":"EJ Mientjes","year":"2006","unstructured":"Mientjes, E. J. et al. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol. Dis. 21, 549\u2013555 (2006).","journal-title":"Neurobiol. Dis."},{"key":"69243_CR60","doi-asserted-by":"publisher","first-page":"108415","DOI":"10.1016\/j.celrep.2020.108415","volume":"33","author":"P Huang","year":"2020","unstructured":"Huang, P., Xiang, X., Chen, X. & Li, H. Somatostatin Neurons Govern Theta Oscillations Induced by Salient Visual Signals. Cell Rep. 33, 108415 (2020).","journal-title":"Cell Rep."},{"key":"69243_CR61","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.neuron.2017.11.033","volume":"96","author":"G Chen","year":"2017","unstructured":"Chen, G. et al. Distinct Inhibitory Circuits Orchestrate Cortical beta and gamma Band Oscillations. Neuron 96, 1403\u20131418.e1406 (2017).","journal-title":"Neuron"},{"key":"69243_CR62","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nature08002","volume":"459","author":"JA Cardin","year":"2009","unstructured":"Cardin, J. A. et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459, 663\u2013667 (2009).","journal-title":"Nature"},{"key":"69243_CR63","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nature07991","volume":"459","author":"VS Sohal","year":"2009","unstructured":"Sohal, V. S., Zhang, F., Yizhar, O. & Deisseroth, K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459, 698\u2013702 (2009).","journal-title":"Nature"},{"key":"69243_CR64","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/nn.4562","volume":"20","author":"J Veit","year":"2017","unstructured":"Veit, J., Hakim, R., Jadi, M. P., Sejnowski, T. J. & Adesnik, H. Cortical gamma band synchronization through somatostatin interneurons. Nat. Neurosci. 20, 951\u2013959 (2017).","journal-title":"Nat. Neurosci."},{"key":"69243_CR65","doi-asserted-by":"publisher","unstructured":"Hayden, D. J., Montgomery, D. P., Cooke, S. F. & Bear, M. F. Visual recognition is heralded by shifts in local field potential oscillations and inhibitory networks in primary visual cortex. J Neurosci https:\/\/doi.org\/10.1523\/JNEUROSCI.0391-21.2021 (2021).","DOI":"10.1523\/JNEUROSCI.0391-21.2021"},{"key":"69243_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fpsyg.2011.00099","volume":"2","author":"KE Mathewson","year":"2011","unstructured":"Mathewson, K. E. et al. Pulsed out of awareness: EEG alpha oscillations represent a pulsed-inhibition of ongoing cortical processing. Front Psychol. 2, 99 (2011).","journal-title":"Front Psychol."},{"key":"69243_CR67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnhum.2010.00186","volume":"4","author":"O Jensen","year":"2010","unstructured":"Jensen, O. & Mazaheri, A. Shaping functional architecture by oscillatory alpha activity: gating by inhibition. Front Hum. Neurosci. 4, 186 (2010).","journal-title":"Front Hum. Neurosci."},{"key":"69243_CR68","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1162\/jocn.2010.21557","volume":"23","author":"BF Handel","year":"2011","unstructured":"Handel, B. F., Haarmeier, T. & Jensen, O. Alpha oscillations correlate with the successful inhibition of unattended stimuli. J. Cogn. Neurosci. 23, 2494\u20132502 (2011).","journal-title":"J. Cogn. Neurosci."},{"key":"69243_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpsycho.2012.07.002","volume":"86","author":"E Basar","year":"2012","unstructured":"Basar, E. A review of alpha activity in integrative brain function: fundamental physiology, sensory coding, cognition and pathology. Int J. Psychophysiol. 86, 1\u201324 (2012).","journal-title":"Int J. Psychophysiol."},{"key":"69243_CR70","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.neuron.2013.09.033","volume":"80","author":"E Stark","year":"2013","unstructured":"Stark, E. et al. Inhibition-induced theta resonance in cortical circuits. Neuron 80, 1263\u20131276 (2013).","journal-title":"Neuron"},{"key":"69243_CR71","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.neuron.2015.05.027","volume":"86","author":"B Amilhon","year":"2015","unstructured":"Amilhon, B. et al. Parvalbumin Interneurons of Hippocampus Tune Population Activity at Theta Frequency. Neuron 86, 1277\u20131289 (2015).","journal-title":"Neuron"},{"key":"69243_CR72","doi-asserted-by":"publisher","unstructured":"Kaplan, E. S. et al. Contrasting roles for parvalbumin-expressing inhibitory neurons in two forms of adult visual cortical plasticity. Elife 5, https:\/\/doi.org\/10.7554\/eLife.11450 (2016).","DOI":"10.7554\/eLife.11450"},{"key":"69243_CR73","doi-asserted-by":"publisher","first-page":"e1009280","DOI":"10.1371\/journal.pcbi.1009280","volume":"17","author":"IC Garwood","year":"2021","unstructured":"Garwood, I. C. et al. A hidden Markov model reliably characterizes ketamine-induced spectral dynamics in macaque local field potentials and human electroencephalograms. PLoS Comput Biol. 17, e1009280 (2021).","journal-title":"PLoS Comput Biol."},{"key":"69243_CR74","doi-asserted-by":"publisher","unstructured":"Adam, E. et al. Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors. bioRxiv https:\/\/doi.org\/10.1101\/2024.04.03.587998 (2024).","DOI":"10.1101\/2024.04.03.587998"},{"key":"69243_CR75","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1523\/JNEUROSCI.2250-20.2021","volume":"41","author":"N Guyon","year":"2021","unstructured":"Guyon, N. et al. Network Asynchrony Underlying Increased Broadband Gamma Power. J. Neurosci. 41, 2944\u20132963 (2021).","journal-title":"J. Neurosci."},{"key":"69243_CR76","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1093\/cercor\/bhx261","volume":"27","author":"JW Yang","year":"2017","unstructured":"Yang, J. W. et al. Optogenetic Modulation of a Minor Fraction of Parvalbumin-Positive Interneurons Specifically Affects Spatiotemporal Dynamics of Spontaneous and Sensory-Evoked Activity in Mouse Somatosensory Cortex in Vivo. Cereb. Cortex 27, 5784\u20135803 (2017).","journal-title":"Cereb. Cortex"},{"key":"69243_CR77","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000329420","volume":"33","author":"SM Paluszkiewicz","year":"2011","unstructured":"Paluszkiewicz, S. M., Martin, B. S. & Huntsman, M. M. Fragile X syndrome: the GABAergic system and circuit dysfunction. Dev. Neurosci. 33, 349\u2013364 (2011).","journal-title":"Dev. Neurosci."},{"key":"69243_CR78","doi-asserted-by":"publisher","unstructured":"Nomura, T. Interneuron Dysfunction and Inhibitory Deficits in Autism and Fragile X Syndrome. Cells 10, https:\/\/doi.org\/10.3390\/cells10102610 (2021).","DOI":"10.3390\/cells10102610"},{"key":"69243_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fnsyn.2017.00015","volume":"9","author":"S Castagnola","year":"2017","unstructured":"Castagnola, S., Bardoni, B. & Maurin, T. The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality. Front. Synaptic Neurosci. 9, 15 (2017).","journal-title":"Front. Synaptic Neurosci."},{"key":"69243_CR80","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1016\/j.neuron.2023.06.009","volume":"111","author":"N Kourdougli","year":"2023","unstructured":"Kourdougli, N. et al. Improvement of sensory deficits in fragile X mice by increasing cortical interneuron activity after the critical period. Neuron 111, 2863\u20132880.e2866 (2023).","journal-title":"Neuron"},{"key":"69243_CR81","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s41593-018-0231-0","volume":"21","author":"A Goel","year":"2018","unstructured":"Goel, A. et al. Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible. Nat. Neurosci. 21, 1404\u20131411 (2018).","journal-title":"Nat. Neurosci."},{"key":"69243_CR82","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1152\/jn.00421.2011","volume":"106","author":"SM Paluszkiewicz","year":"2011","unstructured":"Paluszkiewicz, S. M., Olmos-Serrano, J. L., Corbin, J. G. & Huntsman, M. M. Impaired inhibitory control of cortical synchronization in fragile X syndrome. J. Neurophysiol. 106, 2264\u20132272 (2011).","journal-title":"J. Neurophysiol."},{"key":"69243_CR83","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fncel.2014.00245","volume":"8","author":"CA Cea-Del Rio","year":"2014","unstructured":"Cea-Del Rio, C. A. & Huntsman, M. M. The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome. Front. Cell. Neurosci. 8, 245 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"69243_CR84","doi-asserted-by":"publisher","first-page":"109993","DOI":"10.1016\/j.celrep.2021.109993","volume":"37","author":"G Pouchelon","year":"2021","unstructured":"Pouchelon, G. et al. The organization and development of cortical interneuron presynaptic circuits are area specific. Cell Rep. 37, 109993 (2021).","journal-title":"Cell Rep."},{"key":"69243_CR85","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1152\/jn.90752.2008","volume":"100","author":"JR Gibson","year":"2008","unstructured":"Gibson, J. R., Bartley, A. F., Hays, S. A. & Huber, K. M. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J. Neurophysiol. 100, 2615\u20132626 (2008).","journal-title":"J. Neurophysiol."},{"key":"69243_CR86","doi-asserted-by":"publisher","unstructured":"Qin, M. et al. R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome. Int J Neuropsychopharmacol 18, https:\/\/doi.org\/10.1093\/ijnp\/pyv034 (2015).","DOI":"10.1093\/ijnp\/pyv034"},{"key":"69243_CR87","doi-asserted-by":"publisher","first-page":"152ra128","DOI":"10.1126\/scitranslmed.3004218","volume":"4","author":"C Henderson","year":"2012","unstructured":"Henderson, C. et al. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. Sci. Transl. Med 4, 152ra128 (2012).","journal-title":"Sci. Transl. Med"},{"key":"69243_CR88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s11689-016-9181-6","volume":"9","author":"E Berry-Kravis","year":"2017","unstructured":"Berry-Kravis, E. et al. Arbaclofen in fragile X syndrome: results of phase 3 trials. J. Neurodev. Disord. 9, 3 (2017).","journal-title":"J. Neurodev. Disord."},{"key":"69243_CR89","doi-asserted-by":"publisher","unstructured":"Sinclair, D. et al. GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome. eNeuro 4. https:\/\/doi.org\/10.1523\/ENEURO.0380-16.2017.","DOI":"10.1523\/ENEURO.0380-16.2017"},{"key":"69243_CR90","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s11689-022-09455-9","volume":"14","author":"CR Jonak","year":"2022","unstructured":"Jonak, C. R. et al. Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome. J. Neurodev. Disord. 14, 52 (2022).","journal-title":"J. Neurodev. Disord."},{"key":"69243_CR91","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","volume":"74","author":"A Michalon","year":"2012","unstructured":"Michalon, A. et al. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74, 49\u201356 (2012).","journal-title":"Neuron"},{"key":"69243_CR92","doi-asserted-by":"crossref","unstructured":"Stoppel, L. J., Osterweil, E. K. & Bear, M. F. in Fragile X Syndrome (eds R. Wilemsen & R.F. Kooy) Ch. 9, 173-204 (Academic Press, 2017).","DOI":"10.1016\/B978-0-12-804461-2.00009-3"},{"key":"69243_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34978-4","volume":"8","author":"R Hagerman","year":"2018","unstructured":"Hagerman, R. et al. Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents. Sci. Rep. 8, 16970 (2018).","journal-title":"Sci. Rep."},{"key":"69243_CR94","doi-asserted-by":"publisher","first-page":"718953","DOI":"10.3389\/fpsyt.2021.718953","volume":"12","author":"DC Stoppel","year":"2021","unstructured":"Stoppel, D. C., McCamphill, P. K., Senter, R. K., Heynen, A. J. & Bear, M. F. mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence. Front Psychiatry 12, 718953 (2021).","journal-title":"Front Psychiatry"},{"key":"69243_CR95","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11689-020-09310-9","volume":"12","author":"KA Razak","year":"2020","unstructured":"Razak, K. A., Dominick, K. C. & Erickson, C. A. Developmental studies in fragile X syndrome. J. Neurodev. Disord. 12, 13 (2020).","journal-title":"J. Neurodev. Disord."},{"key":"69243_CR96","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2018.11.047","volume":"398","author":"TH Wen","year":"2019","unstructured":"Wen, T. H., Lovelace, J. W., Ethell, I. M., Binder, D. K. & Razak, K. A. Developmental Changes in EEG Phenotypes in a Mouse Model of Fragile X Syndrome. Neuroscience 398, 126\u2013143 (2019).","journal-title":"Neuroscience"},{"key":"69243_CR97","doi-asserted-by":"publisher","first-page":"e14285","DOI":"10.1111\/psyp.14285","volume":"60","author":"JC Edgar","year":"2023","unstructured":"Edgar, J. C. et al. A comparison of resting-state eyes-closed and dark-room alpha-band activity in children. Psychophysiology 60, e14285 (2023).","journal-title":"Psychophysiology"},{"key":"69243_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78173-0","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Shared oscillatory mechanisms of alpha-band activity in prefrontal regions in eyes open and closed state using a portable EEG acquisition device. Sci. Rep. 14, 26719 (2024).","journal-title":"Sci. Rep."},{"key":"69243_CR99","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0304-3940(98)00122-0","volume":"244","author":"W Klimesch","year":"1998","unstructured":"Klimesch, W., Doppelmayr, M., Russegger, H., Pachinger, T. & Schwaiger, J. Induced alpha band power changes in the human EEG and attention. Neurosci. Lett. 244, 73\u201376 (1998).","journal-title":"Neurosci. Lett."},{"key":"69243_CR100","doi-asserted-by":"publisher","first-page":"121028","DOI":"10.1016\/j.neuroimage.2025.121028","volume":"307","author":"N Zhao","year":"2025","unstructured":"Zhao, N. & Liu, Q. Dissociating the roles of alpha oscillation sub-bands in visual working memory. Neuroimage 307, 121028 (2025).","journal-title":"Neuroimage"},{"key":"69243_CR101","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1523\/JNEUROSCI.0571-23.2023","volume":"43","author":"N Rahmatullah","year":"2023","unstructured":"Rahmatullah, N. et al. Hypersensitivity to Distractors in Fragile X Syndrome from Loss of Modulation of Cortical VIP Interneurons. J. Neurosci. 43, 8172\u20138188 (2023).","journal-title":"J. Neurosci."},{"key":"69243_CR102","doi-asserted-by":"publisher","unstructured":"Veit, J., Handy, G., Mossing, D. P., Doiron, B. & Adesnik, H. Cortical VIP neurons locally control the gain but globally control the coherence of gamma band rhythms. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.036.","DOI":"10.1016\/j.neuron.2022.10.036"},{"key":"69243_CR103","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1093\/cercor\/bhac355","volume":"33","author":"N Wagatsuma","year":"2023","unstructured":"Wagatsuma, N., Nobukawa, S. & Fukai, T. A microcircuit model involving parvalbumin, somatostatin, and vasoactive intestinal polypeptide inhibitory interneurons for the modulation of neuronal oscillation during visual processing. Cereb. Cortex 33, 4459\u20134477 (2023).","journal-title":"Cereb. Cortex"},{"key":"69243_CR104","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fncir.2016.00052","volume":"10","author":"GT Neske","year":"2016","unstructured":"Neske, G. T. & Connors, B. W. Distinct Roles of SOM and VIP Interneurons during Cortical Up States. Front Neural Circuits 10, 52 (2016).","journal-title":"Front Neural Circuits"},{"key":"69243_CR105","doi-asserted-by":"publisher","unstructured":"Norris, J. E. et al. ROC Analysis of Biomarker Combinations in Fragile X Syndrome-Specific Clinical Trials: Evaluating Treatment Efficacy via Exploratory Biomarkers. medRxiv, 2025.2005.2029.25328581 https:\/\/doi.org\/10.1101\/2025.05.29.25328581 (2025).","DOI":"10.1101\/2025.05.29.25328581"},{"key":"69243_CR106","doi-asserted-by":"publisher","first-page":"14223","DOI":"10.1523\/JNEUROSCI.3157-11.2011","volume":"31","author":"SA Hays","year":"2011","unstructured":"Hays, S. A., Huber, K. M. & Gibson, J. R. Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry. J. Neurosci. 31, 14223\u201314234 (2011).","journal-title":"J. Neurosci."},{"key":"69243_CR107","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nn.3415","volume":"16","author":"JT Goncalves","year":"2013","unstructured":"Goncalves, J. T., Anstey, J. E., Golshani, P. & Portera-Cailliau, C. Circuit level defects in the developing neocortex of Fragile X mice. Nat. Neurosci. 16, 903\u2013909 (2013).","journal-title":"Nat. Neurosci."},{"key":"69243_CR108","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fnins.2018.00513","volume":"12","author":"AR Levin","year":"2018","unstructured":"Levin, A. R., Mendez Leal, A. S., Gabard-Durnam, L. J. & O\u2019Leary, H. M. BEAPP: The Batch Electroencephalography Automated Processing Platform. Front Neurosci. 12, 513 (2018).","journal-title":"Front Neurosci."},{"key":"69243_CR109","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fnins.2018.00097","volume":"12","author":"LJ Gabard-Durnam","year":"2018","unstructured":"Gabard-Durnam, L. J., Mendez Leal, A. S., Wilkinson, C. L. & Levin, A. R. The Harvard Automated Processing Pipeline for Electroencephalography (HAPPE): Standardized Processing Software for Developmental and High-Artifact Data. Front. Neurosci. 12, 97 (2018).","journal-title":"Front. Neurosci."},{"key":"69243_CR110","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/aur.2131","volume":"12","author":"CL Wilkinson","year":"2019","unstructured":"Wilkinson, C. L., Levin, A. R., Gabard-Durnam, L. J., Tager-Flusberg, H. & Nelson, C. A. Reduced frontal gamma power at 24 months is associated with better expressive language in toddlers at risk for autism. Autism Res. 12, 1211\u20131224 (2019).","journal-title":"Autism Res."},{"key":"69243_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-7-30","volume":"7","author":"I Winkler","year":"2011","unstructured":"Winkler, I., Haufe, S. & Tangermann, M. Automatic classification of artifactual ICA-components for artifact removal in EEG signals. Behav. Brain Funct. 7, 30 (2011).","journal-title":"Behav. Brain Funct."},{"key":"69243_CR112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","volume":"134","author":"A Delorme","year":"2004","unstructured":"Delorme, A. & Makeig, S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J. Neurosci. Methods 134, 9\u201321 (2004).","journal-title":"J. Neurosci. Methods"},{"key":"69243_CR113","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jneumeth.2010.06.020","volume":"192","author":"H Bokil","year":"2010","unstructured":"Bokil, H., Andrews, P., Kulkarni, J. E., Mehta, S. & Mitra, P. P. Chronux: a platform for analyzing neural signals. J. Neurosci. Methods 192, 146\u2013151 (2010).","journal-title":"J. Neurosci. Methods"},{"key":"69243_CR114","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1152\/physiol.00062.2015","volume":"32","author":"MJ Prerau","year":"2017","unstructured":"Prerau, M. J., Brown, R. E., Bianchi, M. T., Ellenbogen, J. M. & Purdon, P. L. Sleep Neurophysiological Dynamics Through the Lens of Multitaper Spectral Analysis. Physiology 32, 60\u201392 (2017).","journal-title":"Physiology"},{"key":"69243_CR115","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1152\/jn.00106.2010","volume":"104","author":"AB Tort","year":"2010","unstructured":"Tort, A. B., Komorowski, R., Eichenbaum, H. & Kopell, N. Measuring phase-amplitude coupling between neuronal oscillations of different frequencies. J. Neurophysiol. 104, 1195\u20131210 (2010).","journal-title":"J. Neurophysiol."},{"key":"69243_CR116","doi-asserted-by":"crossref","unstructured":"Saravanan, V., Berman, G. J. & Sober, S. J. Application of the hierarchical bootstrap to multi-level data in neuroscience. Neuron Behav. Data Anal. Theory 3 (2020).","DOI":"10.1101\/819334"},{"key":"69243_CR117","doi-asserted-by":"publisher","unstructured":"Kornfeld-Sylla, S. et al. A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-\/y mice. FigShare. https:\/\/doi.org\/10.6084\/m9.figshare.29940884 (2026).","DOI":"10.6084\/m9.figshare.29940884"},{"key":"69243_CR118","doi-asserted-by":"publisher","unstructured":"Kornfeld-Sylla, S. et al. A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-\/y mice. Github. https:\/\/doi.org\/10.5281\/zenodo.18201252 (2026).","DOI":"10.5281\/zenodo.18201252"},{"key":"69243_CR119","unstructured":"Allen Institute for Brain Science (2011). Allen Reference Atlas \u2013 Mouse Brain [brain atlas]. Available from atlas.brain-map.org."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69243-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:03:28Z","timestamp":1770725008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69243-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69243"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69243-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.F.B. is a co-founder of Allos Pharma, developing Arbaclofen for the treatment of Fragile X syndrome. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1497"}}